Welcome to our dedicated page for MACC.U news (Ticker: MACC.U), a resource for investors and traders seeking the latest updates and insights on MACC.U stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MACC.U's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MACC.U's position in the market.
The stockholders of Mission Advancement Corp. approved a Charter Amendment to unwind and redeem all public shares prior to December 30, 2022. The amendment was filed on December 6, 2022, with the termination date set for December 7, 2022. The Company has requested to suspend trading of its Class A common stock and redeem approximately 34 million public shares at $10.07 per share, totaling around $342.8 million. Following the redemptions, only 464,599 shares will remain. The final redemption is expected on December 14, 2022, prior to the Company's liquidation.
Mission Advancement Corp. (NYSE: MACC.U) announced the start of trading for holders of its initial public offering units, allowing separate trading of Class A common stock and warrants from April 23, 2021. The separate shares will trade under symbols 'MACC' for common stock and 'MACC.W' for warrants. The units not separated will continue under 'MACC.U'. The offering was led by Cantor Fitzgerald & Co. and Moelis & Company, with registration effective from March 2, 2021. The press release clarifies it is not an offer to sell or solicit any purchase where unlawful.
Mission Advancement Corp. closed its upsized initial public offering on March 5, 2021, raising gross proceeds of $345 million by issuing 34.5 million units priced at $10.00 each. The offering included 4.5 million units from the underwriters' over-allotment option. Units trade on the NYSE under the ticker MACC.U, comprising one share of Class A common stock and one-third of a redeemable warrant, allowing purchase of additional shares at $11.50. Underwriters include Cantor Fitzgerald & Co and Moelis & Company.
Mission Advancement Corp. announced the pricing of its initial public offering (IPO) for 30 million units at $10.00 each, set to trade on the NYSE under the symbol 'MACC.U' from March 3, 2021. Each unit consists of one Class A common stock share and one-third of a warrant, allowing purchasers to buy additional shares at $11.50. The offering aims to raise $300 million, with underwriters given a 45-day option to purchase an additional 4.5 million units. This IPO will help the company seek partnerships with consumer-focused businesses across various sectors.
